Last reviewed · How we verify
NCT04373135: UC-COVID
Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19
NA trial testing Brief educational video in Covid-19 in 1,971 participants. Completed in 31 January 2021.
31 January 2021
Quick facts
| Lead sponsor | University of California, Los Angeles |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 1,971 |
| Start date | 8 May 2020 |
| Primary completion | 31 January 2021 |
| Estimated completion | 31 January 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Brief educational video
Conditions studied
- Covid-19 — all drugs for Covid-19 →
- Critical Illness — all drugs for Critical Illness →
- Attitude of Health Personnel — all drugs for Attitude of Health Personnel →
- Attitude to Health — all drugs for Attitude to Health →
Sponsor
University of California, Los Angeles
Who can join
18 and older, any sex, with Covid-19 or Critical Illness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The novel coronavirus (COVID-19) is affecting the way many people live their lives, including seeking medical care and maintaining good self-care to keep healthy. Additionally, in the event many people become critically ill at once, COVID-19 has the possibility of overwhelming hospitals to the point where they have to make decisions about how to determine who receives intensive care and life-support measures. Many hospitals as well as local or state governments have been working on policies to determine how to make these decisions. This study seeks to learn about how COVID-19 has affected the way patients and healthcare providers care for themselves and about their thoughts and concerns about policies that may "ration" life-support resources.
Publications & conference data
6 peer-reviewed publications reference this trial (live from Europe PMC):
-
Rapid deployment of a community engagement study and educational trial via social media: implementation of the UC-COVID study.
Wisk LE, Buhr RG. · · 2021 · cited 6× · PMID 34340693 · DOI 10.1186/s13063-021-05467-3 -
Tobacco consumption behavior change during the COVID-19 pandemic is associated with perceived COVID threat.
Loui HF, Li J, Jackson NJ, Romero R, et al · · 2024 · cited 4× · PMID 39407204 · DOI 10.1186/s12889-024-20259-5 -
Promotion of Knowledge and Trust Surrounding Scarce Resource Allocation Policies: A Randomized Clinical Trial.
Buhr RG, Romero R, Wisk LE. · · 2024 · cited 2× · PMID 39422889 · DOI 10.1001/jamahealthforum.2024.3509 -
Bolstering agreement with scarce resource allocation policy using education: a post hoc analysis of a randomized controlled trial.
Buhr RG, Huang CX, Romero R, Wisk LE. · · 2025 · PMID 40229711 · DOI 10.1186/s12913-025-12712-x -
Tobacco consumption behavior change during the COVID-19 pandemic is associated with perceived COVID threat
Loui HF, Li BJ, Jackson PNJ, Wisk LE, et al · · 2023 · DOI 10.21203/rs.3.rs-3143401/v1 -
Rapid Deployment of A Community Engagement Study And Educational Trial Via Social Media: Implementation of The UC-COVID Study
Wisk LE, Buhr RG. · · 2021 · DOI 10.21203/rs.3.rs-359099/v1
Verify or expand the search:
- PubMed search for NCT04373135
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Covid-19
Currently open trials in the same condition.
- NCT05943743 — Hiccups and Obstacles Of E-Learning Among Medical Sudents · recruiting
- NCT04466683 — Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia · Phase 2 · active not recruiting
- NCT04433364 — COPE - COVID-19 in Pregnancy and Early Childhood · active not recruiting
- NCT04568148 — COVID-19 Biorepository · active not recruiting
- NCT04360538 — Long Term Outcomes of Patients With COVID-19 · active not recruiting
Other University of California, Los Angeles trials
Trials by the same sponsor.
- NCT04846517 — rTMS for Aneroxia Nervosa in Youth · NA · not yet recruiting
- NCT06701760 — Sodium Lactate in Severe TBI · Phase 2 · not yet recruiting
- NCT04996667 — Effect of iNO in Patients With Submassive and Massive PE · Phase 2 · withdrawn
- NCT05067387 — Evaluation of Oral THC and CBD in Men and Women · Phase 1 · not yet recruiting
- NCT07534696 — Evaluation of Non-Invasive Pelvic Floor Neuromuscular Stimulation for Urinary Incontinence After Prostatectomy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04373135 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, Los Angeles
- Last refreshed: 30 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04373135.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing